Abstract
Testosterone prescribing for middle-aged and older men in the U.S. rose nearly fourfold from 2000 through 2011. Given the uncertain risk-benefit ratio
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have